131 related articles for article (PubMed ID: 15735726)
1. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.
Wang W; Huper G; Guo Y; Murphy SK; Olson JA; Marks JR
Oncogene; 2005 Apr; 24(16):2705-14. PubMed ID: 15735726
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
4. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
6. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
8. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines.
Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G
Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.
Sato N; Fukushima N; Maitra A; Matsubayashi H; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Cancer Res; 2003 Jul; 63(13):3735-42. PubMed ID: 12839967
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
14. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines.
Pilat MJ; Schwab ED; Yao KL; Pienta KJ
Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912
[TBL] [Abstract][Full Text] [Related]
15. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
16. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
Huper G; Marks JR
Cancer Res; 2007 Apr; 67(7):2990-3001. PubMed ID: 17409405
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D2 expression in familial and sporadic breast cancer.
Fischer H; Chen J; Skoog L; Lindblom A
Oncol Rep; 2002; 9(6):1157-61. PubMed ID: 12375011
[TBL] [Abstract][Full Text] [Related]
19. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]